Skip to content
Open access

A Population Pharmacokinetic Model of Gentamicin in Hospitalized Neonatal Foals.

Sep 2026 · Journal of Veterinary Pharmacology and Therapeutics · 0 citations · 59 references
Medicine

Abstract

Information on safe and effective gentamicin dosing in foals is limited. This study aimed to provide guidance regarding optimal dosing regimens by means of a population pharmacokinetic (popPK) model. Gentamicin plasma concentration of 290 samples from 72 hospitalized foals (≤ 14 days old), treated with intravenous (IV) gentamicin, was measured using a validated LC-MS/MS method. A 2-compartment popPK model was developed with age as a significant covariate on clearance. The final popPK model was used to simulate the commonly used clinical dosing regimens. Mean simulated fAUC0-24H (10th-90th percentile) in respectively 1-day-old and 14-day-old foals following IV administration of 6.6 mg/kg q24h was 66.3 mg/L*h (44.7-91.2) and 41.9 mg/L*h (26.0-61.0) and following 12 mg/kg q36h 120.5 mg/L*h (81.3-165.8) and 76.2 mg/L*h (47.3-110.9). Trough concentrations were < 2 mg/L for both dosing regimens, irrespective of age. Based on a pharmacodynamic target of fAUC0-24H/MIC > 80, the 12 mg/kg q36h regimen has a higher probability of target attainment (PTA) than 6.6 mg/kg q24h. A simulated hypothetical dose of 15 mg/kg q36h demonstrated promising PTA with mean trough values ≤ 2 mg/L. Despite substantial interindividual variability, the model provides a rational basis for selecting a dosing regimen in hospitalized neonatal foals.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.